Cargando...
The effect of spinal cord-injury level on the outcome of neurogenic bladder treatment using OnabotulinumtoxinA
AIM: The aim was to report the effectiveness and safety OnabotulinumtoxinA (Botox, Allergan, Inc., Irvine, CA, USA) intradetrusor injections in spinal cord-injured (SCI) patients with refractory neurogenic detrusor overactivity. And to assess the result based on SCI level. MATERIALS AND METHODS: We...
Guardado en:
| Publicado en: | Urol Ann |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4518367/ https://ncbi.nlm.nih.gov/pubmed/26229318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-7796.152013 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|